Applied DNA Sciences, Inc. (NASDAQ:APDN), announced today that
American & Efird (A&E), a portfolio company of Elevate
Textiles and the world’s foremost manufacturer and distributor of
industrial and consumer sewing thread, embroidery thread and
technical textiles, has announced it will be previewing its new
line of advanced identification threads, branded “Integrity” later
this month. A&E will publicly display this latest breakthrough
at the upcoming Texprocess trade show in Frankfurt Germany.
“One of the big challenges brands face today centers around
authenticity. Loss of revenue, reputation, and brand trust are some
of the potential outcomes of counterfeit products,” said A&E
President, Chris Alt. “We are looking forward to previewing our new
‘Integrity’ line at the upcoming Texprocess show in Frankfurt.”
Well known for its leadership role in innovation, product
quality, and sustainability, A&E supports many of the world’s
top industrial and consumer brands with thread products that
require strict quality and performance. A&E’s new “Integrity”
thread line provides a tool which adds advanced identification for
greater visibility and transparency into their product creation
process.
“Our collaboration with A&E to adopt the CertainT® platform
globally is a key breakthrough for brands, which have not had the
benefit of forensic systems to help them resolve counterfeit and
diversion in their supply chains. We look forward to providing our
full spectrum molecular brand assurance that also includes forensic
expert witness and authentication services to support A&E and
its customers in apparel, footwear, automotive, military and
beyond,” stated Dr. James Hayward, president and CEO of Applied
DNA.
To learn more on A&E’s “Integrity” molecular-tagged thread
products, please visit amefird.com.
Media: Materials and images are available via download.
About American & Efird
A&E, a portfolio company of Elevate Textiles, is the
foremost manufacturer and distributor of premium quality industrial
and consumer sewing thread, embroidery thread and technical
textiles. Producers of apparel, automotive components, home
furnishings, medical supplies, footwear and a diverse range of
industrial products rely on A&E industrial sewing thread to
manufacture their products. Customers select A&E as the
preferred choice for industrial sewing thread, embroidery thread
and technical textiles because of A&E's dedication to providing
its customers with the finest products and services, at the highest
quality, delivered globally. Through its global network, A&E's
products are manufactured in 22 countries, distributed in 50
countries and sold in over 100 countries. In addition to A&E's
steadfast commitment to superior quality and customer service,
A&E is a recognized industry leader in environmental
sustainability and corporate social responsibility and operates its
global facilities with the utmost regard for the safety and health
of its associates employed worldwide. A&E owns or operates 28
manufacturing facilities and employs over 10,000 associates around
the world directly or in partnership with joint venture
partners.
For more information, please visit amefird.com.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and pre-clinical nucleic acid-based
therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe Applied DNA’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA. Actual results could differ materially from those
projected due to its history of net losses, limited financial
resources, limited market acceptance , the uncertainties inherent
in research and development, future clinical data and analysis,
including whether any of Applied DNA’s product candidates will
advance further in the preclinical research or clinical trial
process, including receiving clearance from the U.S. Food and Drug
Administration or equivalent foreign regulatory agencies to conduct
clinical trials and whether and when, if at all, they will receive
final approval from the U.S. FDA or equivalent foreign regulatory
agencies, and various other factors detailed from time to time in
Applied DNA’s SEC reports and filings, including our Annual Report
on Form 10-K filed on December 18, 2018 and our subsequent
quarterly report on Form 10-Q filed on February 7, 2019, and other
reports we file with the SEC, which are available at www.sec.gov.
Applied DNA undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
unanticipated events, unless otherwise required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190508005208/en/
investors: Sanjay M. Hurry, LHA Investor
Relations, 212-838-3777, shurry@lhai.commedia: Meryl
Rader, 781-639-4924, meryl@cgprpublicrelations.comprogram: Jacob
Blackburn, 704-951-2645, jacob.blackburn@amerfird.comMeiLin Wan,
631-240-8849, meilin.wan@adnas.comweb: www.adnas.com,
www.amefird.comtwitter: @APDN, @AmericanEfird
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024